TITLE
Acute myeloid leukemia with CEBPA mutations [AMLSG cohort]: mononuclear cells

SUMMARY
Analysis of mononuclear cells from bone marrow of untreated AML patients with CCAAT/enhancer binding protein alpha double mutation (CEBPAdm) or single mutation (CEBPAsm). Favorable outcome is observed in AML patients with CEBPAdm. Results provide insight into molecular basis of AML classification.

ORGANISM
Homo sapiens

